Advanced search for publications
Enter your keywords
Diabetes prescribing and outcomes overview – supplementary data to Diabetes therapeutic report
Overview Overview of changes in primary care prescribing for the management of diabetes and trends in hospital admissions outcomes data for the diabetic patient population. This is a supplementary data report to be used alongside the Diabetes therapeutic report to support understanding of the impact of diabetes prescribing and interventions, alongside monitoring patient population health […]
Drugs used in Diabetes
This report looks at prescribing trends in primary care for Drugs used in Diabetes at SICBL and ICB level with particular focus on insulins, anti-diabetic drugs and diagnostic & monitoring devices. Prescribing data is weighted with QOF registers, and also uses HES data to measure prescribing outcomes. NEW – we now also produce a supplementary […]
Fezolinetant – Prescribing Information leaflet
Prescribing information leaflets have been developed to support clinicians in the prescribing of drugs classified as Green, Green (following specialist initiation) or Green (following specialist recommendation initiation) drugs on the local formularies. These templates are provided to the North West and North East and Yorkshire ICBs for localisation and approval through standard ICB processes. Prescribers […]
Switching from disposable to reusable insulin pens
This document outlines the benefits of appropriate switching from disposable to reusable insulin pens, highlighting advantages for patients, the environment, and potential cost savings. It also provides practical recommendations for implementation by medicines optimisation teams
NHS Medicines Optimisation Opportunities Dashboard
At the end of July 2023 NHSE published guidance titled “National medicines optimisation opportunities 2023/24”. This guidance describes the 16 national medicines optimisation opportunities for the NHS in 2023/24, and signposts to resources to help with their implementation. It recommends Integrated Care Boards (ICBs) choose at least five medicines optimisation opportunities to focus and deliver […]
Medicines value tracker – Metformin 1g tablets; opportunity savings realised
The purpose of the Medicines value bulletin tracker publications are to support ICBs in monitoring progress and identifying remaining potential opportunity savings, for the Medicines value opportunities already identified in the RDTC Medicines Value Bulletin series. The MVB tracker publications for Metformin 1g IR tablets cover all 7 ICBs across the North of England. Please […]
Formulary assessment – Hydrocortisone sodium phosphate 5mg/5ml, 10mg/5ml oral solutions
Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies. The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The […]
Budget impact of metformin 1g immediate release tablet prescribing
The purpose of this bulletin is to highlight the rapid increase in price of metformin 1g tablets over the last year, and to raise awareness of the difference in price of metformin 1g immediate release (IR) tablets compared with 500mg IR tablets. It considers the potential budget impact to primary care of prescribing metformin 1g […]
Formulary assessment – Calcifediol soft capsules
Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies. The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The […]
Social Prescribing: Evidence and Outcomes
Strategic Insight reports are designed to support strategic objectives and planning by Integrated Care System leaders. Through the analysis of data and communication with key stakeholders across the ICS, interventions to be undertaken by the ICS are proposed to Integrated Care Boards or associated committees. Social prescribing has been proposed as a mechanism to improve […]